Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mastbergen, S. C.
Right arrow Articles by Bijlsma, J. W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mastbergen, S. C.
Right arrow Articles by Bijlsma, J. W. J.
Related Collections
Right arrow Osteoarthritis and Cartilage
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2002; 41: 801-808
© 2002 British Society for Rheumatology

Original Papers

Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage

S. C. Mastbergen, F. P. J. G. Lafeber and J. W. J. Bijlsma

Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands

Objectives. This study evaluated the in vitro effect of the selective cyclooxygenase-2 (COX) inhibitor celecoxib on cartilage matrix turnover under normal and inflammatory conditions.

Methods. Healthy human articular cartilage tissue alone, in co-culture with peripheral blood mononuclear cells (PBMC) or in the presence of interleukin 1 (IL-1ß) plus tumour necrosis factor {alpha} (TNF-{alpha}) was cultured for 7 days in the presence of celecoxib. Changes in cartilage matrix turnover were measured.

Results. No direct effects of celecoxib on healthy normal cartilage were found. Both PBMC and IL-1ß plus TNF-{alpha} induced strong inhibition of cartilage proteoglycan synthesis and significant enhancement of the release of proteoglycans, diminishing proteoglycan content. Celecoxib was able to reverse these adverse effects up to complete normalization.

Conclusions. The results suggest that, under the influence of inflammation, COX-2 is up-regulated, which results in disturbance of cartilage matrix turnover. Celecoxib, by diminishing COX-2 activity, prevents these adverse effects without having a direct effect on healthy cartilage.

KEY WORDS: Selective COX-2 inhibitor, Human cartilage tissue, Proteoglycan turnover, Inflammation; IL-1ß, TNF-{alpha}.

Correspondence to: F. P. J. G. Lafeber, University Medical Center Utrecht, Room F02.127, P.O. Box 85500, 3508GA Utrecht, The Netherlands.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. Ferretti, R. Gassner, Z. Wang, P. Perera, J. Deschner, G. Sowa, R. B. Salter, and S. Agarwal
Biomechanical Signals Suppress Proinflammatory Responses in Cartilage: Early Events in Experimental Antigen-Induced Arthritis
J. Immunol., December 15, 2006; 177(12): 8757 - 8766.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
S. C. Mastbergen, A. C. Marijnissen, M. E. Vianen, B. Zoer, P. M. van Roermund, J. W. Bijlsma, and F. P. Lafeber
Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis
Rheumatology, April 1, 2006; 45(4): 405 - 413.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.